Sobre ABBV
AbbVie Inc. é uma research-based biopharmaceutical company focada em the discovery, development, fabricação, e commercialization of inovadores medicines e therapies em todo o mundo. Com sede em North Chicago, Illinois, e fundada em 2012 as a spin-off from Abbott Laboratories, it emprega aproximadamente 55,000 funcionários e opera primarily na pharmaceuticals e biotechnology sector. Key produtos include Humira, a líder treatment for autoimmune diseases como rheumatoid arthritis, Crohn’s disease, e psoriasis; Skyrizi e Rinvoq for immunology indications like plaque psoriasis e ulcerative colitis; Imbruvica for blood cancers; e Botox for neurological conditions e aesthetics following the 2020 Allergan acquisition. AbbVie Inc. mantém uma robust pipeline addressing immunology, oncology, neuroscience, e other therapeutic areas, with recent advancements in treatments for essential tremor e kidney disease. Its presença global underscores its significant role in advancing healthcare solutions e contributing to the biopharmaceutical industry’s growth.
